Back
Corvus Pharmaceuticals Stock Predictions
How to Turn the AI Energy Crisis into BIG Profits
And investors who move now into one technology could make a whole lot of money.
Sell
12
CRVS
Corvus Pharmaceuticals
Last Price:
$5.04
Seasonality Move:
-9.57%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--hereCorvus Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Corvus Pharmaceuticals has on average historically risen by 27.6% based on the past 8 years of stock performance.
-
Corvus Pharmaceuticals has risen higher in 2 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Corvus Pharmaceuticals Stock Undervalued?The current Corvus Pharmaceuticals [CRVS] share price is $5.00. The Score for CRVS is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
CRVS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Corvus Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Corvus Pharmaceuticals has on average historically risen by 27.6% based on the past 8 years of stock performance.
Corvus Pharmaceuticals Stock Rating
Sell
12
Corvus Pharmaceuticals (CRVS)
is a Sell
Is Corvus Pharmaceuticals overpriced?
-
Corvus Pharmaceuticals has risen higher in 2 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Corvus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
corvuspharma.com
52-Week Data
52-Week High:
10.00
52-Week Low:
1.30
Prediction Charts
Market Cap:
321.3M
Price in USD:
5.00
Volume:
2.6M
Beta:
1.06
Technical Analysis
SMA50:
8.03
SMA100:
6.25
SMA200:
4.09
52-Wk Change:
220.51%
Stock Predictions
-
Is Corvus Pharmaceuticals stock public?Yes, Corvus Pharmaceuticals is a publicly traded company.
-
What is the Corvus Pharmaceuticals stock quote today?The Corvus Pharmaceuticals stock price is 5.00 USD today.
-
How to buy Corvus Pharmaceuticals stock online?You can buy Corvus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 8.16 | 8.28 | 8.28 | 7.95 |
| Dec-4 | 8.20 | 8.03 | 8.36 | 8.01 |
| Dec-5 | 8.03 | 8.13 | 8.29 | 8.00 |
| Dec-6 | 8.12 | 8.26 | 8.49 | 7.98 |
| Dec-9 | 8.27 | 8.15 | 8.43 | 8.00 |
| Dec-10 | 8.20 | 8.02 | 8.49 | 7.98 |
| Dec-11 | 8.03 | 8.11 | 8.25 | 7.88 |
| Dec-12 | 7.96 | 8.08 | 8.33 | 7.96 |
| Dec-13 | 8.07 | 7.38 | 8.22 | 7.29 |
| Dec-16 | 7.28 | 6.90 | 7.40 | 6.88 |
| Dec-17 | 6.44 | 7.39 | 7.44 | 6.44 |
| Dec-18 | 5.00 | 4.71 | 5.20 | 3.77 |
| Dec-19 | 4.67 | 5.09 | 5.10 | 4.30 |
| Dec-20 | 5.02 | 5.00 | 5.34 | 4.73 |
Corvus Pharmaceuticals Earnings
Corvus Pharmaceuticals Earnings Report: Per Share Corvus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corvus Pharmaceuticals Forecast Revenue Growth
Corvus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Corvus Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.46 per share.
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.